MAGDALENA JARZABEK: Open Payments
NPI 1093016479 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$927 in 36 payments from 11 companies in 2025. Trend: 2023 $311 · 2024 $771 · 2025 $927
Food & beverage: $927
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $248 |
| ABBVIE INC. | 3 | $178 |
| Otsuka America Pharmaceutical, Inc. | 4 | $94 |
| Lundbeck LLC | 4 | $87 |
| Amgen Inc. | 4 | $75 |
| Exact Sciences Corporation | 3 | $68 |
| Lilly USA, LLC | 3 | $64 |
| PFIZER INC. | 2 | $48 |
| Astellas Pharma US Inc | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $22 |
Products named: REXULTI, BOTOX, Wegovy, OTEZLA, Cologuard Collection Kit, Rybelsus, PREVNAR 20, MOUNJARO.
Industry payments across IL — which companies pay providers there.
